MedPath

Comparison Between Maternal Complications of Chromic Catgut and Vicryl Rapid Sutures Used for Episiotomy Repair

Not Applicable
Completed
Conditions
Episiotomy Extended by Laceration
Episiotomy Wound
Registration Number
NCT07073131
Lead Sponsor
Huma Ijaz
Brief Summary

Total 202 patients fulfilling the selection criteria were enrolled from labor room and underwent episiotomy. At end of procedure, females were randomly divided in two groups. In group A, females underwent suturing by using vicryl rapide. In group B, females underwent suturing by using chromic catgut. After 24 hours of delivery, females were examined for pain score. After 7 days, females were examined for wound infection, inflammation and dehiscence. All this information was recorded in proforma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
202
Inclusion Criteria
  • Primigravida of age 18-35 years
  • Gestational age during 37-40 weeks
Exclusion Criteria
  • Females with abnormal placenta, non-cephalic presentation, multiple fetus, premature rupture of membranes, unclean vaginal examination.
  • pre-delivery hemoglobin <9 g/dl,
  • Manual removal of placenta
  • Vulvar hematoma and vaginal tears

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Wound dehiscence7 days

Wound dehiscence was labeled if there was partial or total separation of previously approximated wound edges, due to a failure of proper wound healing within 7 days of episiotomy.

Wound Infection7 days

Wound infection was labeled if participant developed pain and pus discharge at wound site, along with fever (\>100F) within 7 days of episiotomy.

Post surgical pain7 days

After 24 hours of episiotomy participants were examined for pain score by using visual analogue scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CMH Gujranwala

🇵🇰

Gujrānwāla, Punjab, Pakistan

CMH Gujranwala
🇵🇰Gujrānwāla, Punjab, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.